Mevion Medical Systems has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Mevion S250i proton therapy system.
The intensity-modulated proton therapy device features the company's Hyperscan pencil-beam scanning technology, which incorporates energy layer switching and Mevion's adaptive aperture automated proton collimation for proton radiation treatments.
The first Mevion S250i system was installed at MedStar Georgetown University Hospital in Washington, DC.
